269 related articles for article (PubMed ID: 2302870)
21. Effects of human recombinant erythropoietin on inflammatory status in peritoneal dialysis patients.
Aguilera A; Bajo MA; Díez JJ; Ruiz-Caravaca ML; Vicenta Cuesta M; Alvarez V; Codoceo R; Selgas R
Adv Perit Dial; 2002; 18():200-5. PubMed ID: 12402619
[TBL] [Abstract][Full Text] [Related]
22. Influence of recombinant human erythropoietin treatment on cortisol responses to insulin-induced hypoglycemia in CAPD patients.
Díez JJ; Iglesias P; Sastre J; Gómez-Pan A; Selgas R; Romero JR; Méndez J
Adv Perit Dial; 1993; 9():336-41. PubMed ID: 8105958
[TBL] [Abstract][Full Text] [Related]
23. [Effectiveness of and tolerance to human recombinant erythropoietin in the treatment of kidney failure anemia in children undergoing continuous peritoneal dialysis. Multicenter study].
Parchoux B; Broyer M; Cochat P; Burguet A; Menget A; Benoît D; Nivet H; Fischbach M; Geisert J; Dabout D
Pediatrie; 1993; 48(5):397-401. PubMed ID: 7777395
[TBL] [Abstract][Full Text] [Related]
24. Intraperitoneal administration of recombinant human erythropoietin.
Frenken LA; Struijk DG; Coppens PJ; Tiggeler RG; Krediet RT; Koene RA
Perit Dial Int; 1992; 12(4):378-83. PubMed ID: 1420497
[TBL] [Abstract][Full Text] [Related]
25. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
26. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
Zehnder C; Blumberg A
Schweiz Med Wochenschr; 1990 Feb; 120(7):217-20. PubMed ID: 2309110
[TBL] [Abstract][Full Text] [Related]
27. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients.
Boelaert JR; Schurgers ML; Matthys EG; Belpaire FM; Daneels RF; De Cre MJ; Bogaert MG
Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207
[TBL] [Abstract][Full Text] [Related]
28. [Maintenance therapy on the anemia in continuous ambulatory peritoneal dialysis (CAPD) patients using subcutaneous administration of recombinant human erythropoietin fortnightly--a multicenter trial].
Kubota M; Kawaguchi Y; Nomoto Y; Tsuchida H; Nihei H; Kubo K; Omori Y; Babazono T; Ogura Y; Hara S
Nihon Jinzo Gakkai Shi; 1993 Sep; 35(9):1081-90. PubMed ID: 8230819
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis].
Zelichowski G; Lubas A; Sienkiewicz M; Janusz E; Wańkowicz Z
Pol Merkur Lekarski; 2008 Apr; 24(142):312-5. PubMed ID: 18634362
[TBL] [Abstract][Full Text] [Related]
30. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
[TBL] [Abstract][Full Text] [Related]
31. Intraperitoneal recombinant human erythropoietin therapy: influence of the duration of continuous ambulatory peritoneal dialysis treatment and peritonitis.
Huang TP; Lin CY
Am J Nephrol; 1995; 15(4):312-7. PubMed ID: 7573189
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of treating anemia in patients undergoing chronic dialysis with small doses of human recombinant erythropoietin].
Marusza W; Matuszkiewicz-Rowińska J; Tomik Z; Andrzejewski A; Rokicka M; Paszkowska M; Drygieniec D; Bobilewicz D; Zawadzka M; Abbas-Fatah A
Pol Tyg Lek; 1995 Oct; 50(40-44):15-8, 31. PubMed ID: 8650050
[TBL] [Abstract][Full Text] [Related]
33. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
Sulowicz W; Locatelli F; Ryckelynck JP; Balla J; Csiky B; Harris K; Ehrhard P; Beyer U;
Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
[TBL] [Abstract][Full Text] [Related]
34. [Single weekly dose of recombinant erythropoietin in children with chronic renal insufficiency].
Guízar JM; Gutiérrez MJ; Sánchez G; Kornhauser C
Rev Invest Clin; 1996; 48(3):173-7. PubMed ID: 8966377
[TBL] [Abstract][Full Text] [Related]
35. Erythropoietin with oral iron in peritoneal and hemodialysis patients. A comparison in an inner city population.
Raja R; Bloom E; Goldstein M; Johnson R
ASAIO J; 1993; 39(3):M578-80. PubMed ID: 8268603
[TBL] [Abstract][Full Text] [Related]
36. Effect of erythropoietin in continuous ambulatory peritoneal dialysis patients: comparison between intravenous and intraperitoneal administration.
Nasu T; Mitui H; Shinohara Y; Hayashida S; Ohtuka H
Perit Dial Int; 1992; 12(4):373-7. PubMed ID: 1420496
[TBL] [Abstract][Full Text] [Related]
37. [Erythropoietin administration to preterm infants: comparison between subcutaneous and intravenous route].
Rigourd V; Kieffer F; Dommergues MA; Ayachi A; Assaf Z; Mohamed I; Voyer M; Magny JF
Arch Pediatr; 2004 Apr; 11(4):319-26. PubMed ID: 15051090
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and hematologic response to subcutaneous administration of recombinant human erythropoietin in children undergoing long-term peritoneal dialysis: a multicenter study.
Montini G; Zacchello G; Perfumo F; Edefonti A; Bassi S; Cantaluppi A; Sarchi C; Cazzin M; Ferrari V; Boccazzi A
J Pediatr; 1993 Feb; 122(2):297-302. PubMed ID: 8429450
[TBL] [Abstract][Full Text] [Related]
39. Iron dextran treatment in peritoneal dialysis patients on erythropoietin.
Suh H; Wadhwa NK
Adv Perit Dial; 1992; 8():464-6. PubMed ID: 1361849
[TBL] [Abstract][Full Text] [Related]
40. Effect of subcutaneous administration of recombinant human erythropoietin on plasma protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis.
Lai KN; Yin JA; Li PK; Yuen PM; Lui SF
Int J Artif Organs; 1992 May; 15(5):264-8. PubMed ID: 1601509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
